Abstract
While it is understandable that proliferating cells should be more sensitive than resting cells to antimetabolites—drugs that derange DNA synthesis—it is not so obvious that other anti-cancer drugs, in particular the alkylating agents, should act in the same way1–3. The greater sensitivity of proliferating cells to such agents is not confined to malignant tissues: normal haematopoietic cells show increased susceptibility after recruitment into cell division4. Moreover, the various alkylating agents have different effects on proliferating nonmalignant cells; in normal bone marrow, recovery is more rapid5 and greater6 after treatment with some drugs (for example, cyclophosphamide and nitrogen mustard) than others (such as nitrosoureas and mitomycin C). We now provide evidence in support of the hypothesis that there are two distinct groups of alkylating agent: those whose uptake into the cell depends on a membrane transport mechanism (that is, carrier-dependent) and those whose uptake is not so dependent (carrier-independent).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bruce, W. R., Meeker, B. E. & Valeriote, F. A. J. natn. Cancer Inst. 37, 233–245 (1966).
Valeriote, F. & van Putten, L. Cancer Res. 35, 2619–2630 (1975).
Bruce, W. R., Meeker, B. E., Powers, W. E. & Valeriote, F. A. J. natn. Cancer Inst. 42, 1015–1025 (1969).
Bruce, W. R. & Meeker, B. E. J. natn. Cancer Inst. 38, 401–405 (1967).
Bergsagel, D. E. Can. med. Ass. J. 104, 31–36 (1971).
Botnick, L. E., Hannon, E. C. & Hellman, S. Nature 262, 68–70 (1976).
Rozenszajn, L. A., Shoham, D. & Kalechman, I. Immunology 29, 1041–1055 (1975).
Claesson, M. H., Rodger, M. B., Johnson, G. R., Whittingham, S. & Metcalf, D. Clin. exp. Immun. 28, 526–534 (1977).
Robins, J. H. Science 146, 1648–1654 (1964).
Byfield, J. E., Calabro-Jones, P., Murnane, J., Seagren, S. L. & Ward, J. Proc. Am. Ass. Cancer Res. 20, 136 (1979).
Vistica, D. T., Toal, J. N. & Rabinovitz, M. Cancer Treat. Rep. 60, 1363–1367 (1976).
Begleiter, A., Froese, E. K. & Goldenberg, G. J. Cancer Lett. 10, 243–251 (1980).
Redwood, W. R. & Colvin, M. Cancer Res. 40, 1144–1149 (1980).
Goldenberg, G. J., Vanstone, C. L., Israels, L. A., Ilse, D. & Bihler, I. Cancer Res. 30, 2285–2291 (1970).
Inaba, M. Int. J. Cancer 11, 231–236 (1973).
Byfield, J. E. & Calabro-Jones, P. Proc. Am. Ass. Cancer Res. 22, 229 (1981).
Cvitkovic, E., Spaulding, J., Bethune, V., Martin, J. & Whitmore, W. F. Cancer 39, 1357–1361 (1977).
Poulter, L. W. & Turk, J. L. Nature new Biol. 238, 17–18 (1972).
Wakaki, S. Antibiotics Chemother. 8, 228–240 (1958).
Nagourney, R. A., Fox, P. & Schein, P. S. Cancer Res. 38, 65–68 (1978).
Kohn, K. W. Cancer Res. 37, 1450–1454 (1977).
Lown, J. W., McLaughlin, L. W. & Chang, Y.-M. Bioorg. Chem. 7, 97–100 (1978).
Iyer, V. N. & Szybalski, W. Proc. natn. Acad. Sci. U.S.A. 50, 355–362 (1963).
Hill, B. T., Jerman, M. & Harrap, K. R. J. med. Chem. 14, 614–618 (1971).
Begleiter, A., Lam, H.-Y. P. & Goldenberg, G. J. Cancer Res. 37, 1022–1027 (1977).
Senn, J. S. & McCulloch, E. A. Expl Hemat. 20, 8–9 (1970).
Bergsagel, D. E., Robertson, G. L. & Hasselback, R. Can. med. Ass. J. 98, 532–538 (1968).
Valeriote, F. A., Collins, D. C. & Bruce, W. R. Radiat. Res. 33, 501–511 (1968).
De Vita, V. T. et al. Cancer Res. 25, 1876–1881 (1965).
Crooke, S. T. & Bradner, W. T. Cancer treat. Rev. 31, 121–139 (1976).
Bergsagel, D. E., Griffith, K. M., Haut, A. & Stuckey, W. J. Jr Adv. Cancer Res. 10, 311–359 (1967).
Haas, R. J., Rohruber, W., Netzel, B. & Lau, E. Cancer Treat. Rep. 63, 377–383 (1979).
Marsh, J. C. Cancer Res. 36, 1853–1882 (1976).
Trainor, K. J. & Morley, A. A. J. natn. Cancer Inst. 57, 1237–1239 (1976).
Chabner, B. A. et al. Cancer Chemother. Rep. (1) 57, 361–363 (1973).
Trainor, K. J., Seshadri, R. S. & Morley, A. A. Leukemia Res. 3, 205–210 (1979).
Schabel, F. M. Jr, Trader, M. W., Laster, W. R. Jr, Corbett, T. H. & Griswold, D. P. Jr, Cancer Treat. Rep. 63, 1459–1473 (1979).
Zwelling, L. A., Michaels, S., Schwartz, H., Dobson, P. P. & Kohn, K. W. Cancer Res. 41, 640–649 (1981).
Reid, B. D. & Walker, I. G. Cancer Res. 26, 1801–1805 (1966).
Roberts, J. J., Crathorn, A. R. & Brent, T. P. Nature 218, 970–972 (1968).
Erickson, L. C., Osieka, R. & Kohn, K. W. Cancer Res. 38, 802–808 (1978).
Erickson, L. C., Bradley, M. O., Ducore, J. M., Ewig, R. A. G. & Kohn, K. W. Proc. natn. Acad. Sci. U.S.A. 77, 467–471 (1980).
Calcutt, G. & Connors, T. A. Biochem. Pharmac. 12, 839–845 (1963).
Schabel, F. M. Jr, Trafer, M. W., Laster, W. R. Jr, Wheeler, G. P. & Witt, M. H. Antibiotics Chemother. 23, 200–215 (1978).
Schabel, F. M. Jr, Cancer Treat. Rep. 60, 665–698 (1976).
Murnane, J. P., Byfield, J. E., Ward, J. F. & Calabro-Jones, P. Nature 285, 326–329 (1980).
Fraval, H. N. A. & Roberts, J. J. Cancer Res. 39, 1793–1797 (1979).
Lieberman, I. & Ove, P. Proc. natn. Acad. Sci. U.S.A. 45, 872–877 (1959).
Szybalski, W. Expl Cell Res. 18, 588–591 (1959).
Lin, A. J. et al. J. med. Chem. 16, 1268–1271 (1973).
Byfield, J. E. et al. Br. J. Cancer 43, 669–683 (1981).
Evans, R. G. & Norman, A. Nature 217, 455–456 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Byfield, J., Calabro-Jones, P. Carrier-dependent and carrier-independent transport of anti-cancer alkylating agents. Nature 294, 281–283 (1981). https://doi.org/10.1038/294281a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/294281a0
This article is cited by
-
Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation
Cancer Chemotherapy and Pharmacology (1992)
-
Nitrosourea and nitrosocarbamate derivatives of the antiestrogen tamoxifen as potential estrogen receptor-mediated cytotoxic agents in human breast cancer cells
Breast Cancer Research and Treatment (1986)
-
Enhancement ofin vitro chemotherapeutic activity by dimethylsulfoxide
Clinical & Experimental Metastasis (1985)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.